Arthneeti
Latest: Chemplast Sanmar Ltd Q1 FY27 (Apr–Jun 2026) results →This page is Q3 FY26 (Oct–Dec 2025).All Q3 FY26 results →
CS

Chemplast Sanmar Ltd

Q3 FY26Chemicals & Petrochemicals

Chemplast Sanmar Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management said on revenue, margins and capex.

Price₹177
Market cap₹2.9K Cr
Updated23 Aug 2026
Read3 min read

The short version

R32 Plant: Targeting 14,000 tons capacity with phased commissioning; first full year revenue expected around INR 550 crores from ~11,000 tons production. The company is optimistic about sustainable growth ahead, supported by improving market sentiment, particularly in Suspension PVC.

From Chemplast Sanmar Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • R32 Plant: Targeting 14,000 tons capacity with phased commissioning; first full year revenue expected around INR 550 crores from ~11,000 tons production.
  • Custom Manufacturing Chemicals Division (CMCD): INR 1,000 crores revenue target by FY 2027-28, though delayed by 2-3 quarters due to ramp-up and market factors.
  • Suspension PVC: Demand expected to recover strongly in H2 FY 2026 after a flat first 9 months; breakeven expected by Feb-Mar at PBT level.

2 more points from Chemplast Sanmar Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Chemplast Sanmar Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Current and future capex primarily includes the commissioning and expansion of the R32 plant and residual capex related to CMC (Custom Manufactured Chemicals) expansions.
  • The R32 plant expansion involves:
  • Swing plant of 2,000 tons operational by end of current quarter.
  • Additional 2,000-ton plant by Q1 next year.
  • Last 10,000-ton plant by end of calendar year.
  • No large capex planned beyond these; the rest is mainly maintenance capex.
  • Details on maintenance capex and segment-wise capex can be provided offline.

2 more points from Chemplast Sanmar Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Chemplast Sanmar Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Some related insights include: - Custom Manufactured Chemicals (CMC) business: The pipeline remains strong with ongoing customer engagements and new product developments, though there is a delay in ramp-up due to agrochemical industry slowdown. Management remains confident of reaching INR 1,000 crores target by FY '27-'28. - For the R32 plant, commercial sales are expected to start post commissioning by end of the current quarter, with initial capacity largely targeted at the domestic market and export mix expected with full capacity. For detailed order book or pending order data, contacting the company or Investor Relations directly is recommended.

Chemplast Sanmar Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.3K Cr, net loss ₹45 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Chemplast Sanmar's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Neochem Bio (Q3 FY26)

    Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and

  • Thirumalai Chem. (Q3 FY26)

    Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran

  • IVP (Q3 FY26)

    Q3 FY26 Revenue from Operations: ₹144.97 crore . Key investor presentation takeaways from IVP's Q3 FY26 investor presentation — and how it ranks against sector

  • Gujarat Alkalies (Q3 FY26)

    3,144.48 Crores, down from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks agai

Compare:vs Solar Industriesvs Pidilite Inds.vs SRF

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Chemplast Sanmar Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Chemplast Sanmar Ltd Q3 FY26 results?

R32 Plant: Targeting 14,000 tons capacity with phased commissioning; first full year revenue expected around INR 550 crores from ~11,000 tons production. The company is optimistic about sustainable growth ahead, supported by improving market sentiment, particularly in Suspension PVC.

What is Chemplast Sanmar Ltd share price analysis?

Chemplast Sanmar Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹2,911 Cr. Investors should review the full earnings analysis for detailed insights.

Is Chemplast Sanmar Ltd planning capital expenditure?

Current and future capex primarily includes the commissioning and expansion of the R32 plant and residual capex related to CMC (Custom Manufactured Chemicals) expansions.

Keep Chemplast Sanmar Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.